SCHEMBL3664397

SCHEMBL3664397

CC(C)CC1c2cccc(C#N)c2CN1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.36
MTNR1B P49286 1/20 0.34
DPP4 P27487 2/20 0.34
FAP Q12884 2/20 0.34
DPP8 Q6V1X1 2/20 0.34
DPP9 Q86TI2 2/20 0.34
ABCB1 P08183 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
AR P10275 1/20 0.33
DRD4 P21917 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALDH1A1 P00352 1/20 0.33
DRD2 P14416 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
ACE P12821 1/20 0.32
S1PR1 P21453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2121619 0.88 NOTUM (0.42) NOTUMMTNR1BABCB1ABCG2AR
SCHEMBL2121978 0.77 ABCB1 (0.39) NOTUMMTNR1BABCB1ABCG2AR
SCHEMBL3664396 0.75 NOTUM (0.38) NOTUMARDRD4ALDH1A1HTR2C
SCHEMBL2122064 0.72 ABCB1 (0.43) MTNR1BABCB1ABCG2ACEKDM4E
SCHEMBL2123453 0.71 NOTUM (0.41) NOTUMABCB1ABCG2ARDRD4
SCHEMBL2123210 0.70 MTNR1B (0.45) MTNR1BDRD2
SCHEMBL2121421 0.69 KIF11 (0.38) MTNR1BDPP8DPP9DPP7ACE
SCHEMBL3664188 0.68 MTNR1B (0.39) MTNR1BDPP4FAPDPP8DPP9
SCHEMBL2126330 0.68 ABCB1 (0.39) MTNR1BABCB1ABCG2ACEKDM4E
SCHEMBL17670976 0.68 DRD1 (0.61) ARALDH1A1HTR2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222670-A1 OXADIAZOLE DERIVATIVES FOR USE AS S1P1 AGONISTS IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS Glaxo Group Limited (GB) 2010-09-01 EP disclosed
WO-2009080729-A1 OXADIAZOLE DERIVATIVES FOR USE AS S1P1 AGONISTS IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS GLAXO GROUP LIMITED (GB) 2009-07-02 WO disclosed